Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile

Audrey Burban(Centre National de la Recherche Scientifique), Ahmad Sharanek(Université de Bordeaux)
EMBO Molecular Medicine
February 3, 2025
Cited by 3


Related Papers